跳至主要内容
临床试验/NCT05629130
NCT05629130
招募中
不适用

Embolization in Hereditary Coagulopathies

University of Sao Paulo General Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年1月16日最近更新:

概览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Reduction of synovium thickness by embolization

概览

简要总结

This is a longitudinal, prospective study, which will include 30 subjects with hereditary coagulopathies, with arthropathy, chronic synovitis resulting from hemarthrosis of the elbows, knees and/or ankles followed up at the Centro de Hemofilia HCFMUSP, after approval by the ethics and research committee.

They will undergo imaging tests (X-rays and Magnetic Resonance of knee, elbow, or ankle), physical, pain, quality of life and functional assessments (Hemophilia Joint Health Score, Functional Independence Score in Hemophilia, Perimeter, Test Timed up and Go, 30 second sit and stand test, Haemophilia - Adult - Quality of Life questionnaire (HAEM-A-QoL), Knee Injury and Osteoarthritis Outcome Score, EQ-5D, numerical rating scale for pain and embolization procedure (superselective embolization of target arteries with spherical microparticles Embosphere 100-300 micrometers (Biosphere Medical, Roissy, France), until partial vascular stasis and decharacterization of pathological synovial enhancement.

These evaluations will be performed at baseline, 1, 3, 6, 12, 24, 36, 48 and 60 months after the procedure.

详细描述

Longitudinal, prospective study, which will include 30 subjects with hereditary coagulopathies, with arthropathy, chronic synovitis resulting from hemarthrosis of the elbows, knees and/or ankles followed up at the Centro de Hemophilia do Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, i.e. HC-FMUSP), after approval by the ethics and research committee and registry at the clinical trials.

Patients will be evaluated by imaging (X-rays and Magnetic Resonance of the affected joint, i.e., knee, elbow, and/or ankle); physical and functional assessments (Hemophilia Joint Health Score, Functional Independence Score in Hemophilia, Perimeter of the affected joint(s), Test Timed up and Go, 30 second sit and stand test, Knee Injury and Osteoarthritis Outcome Score (KOOS); quality of life (Haemophilia - adult - quality of life questionnaires (HAEM-A-QoL), Knee Injury and Osteoarthritis Outcome Score (KOOS), EQ-5D; pain measured by numerical rating scale.

Volunteers will be submitted to embolization procedure (superselective embolization of target arteries with spherical microparticles embosphere 100-300 micrometers (Biosphere Medical, Roissy, France) of the affected joint(s), until partial vascular stasis and decharacterization of pathological synovial enhancement.

These evaluations will be performed at baseline, 1, 3, 6, 12, 24, 36, 48 and 60 months after the procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

no masking - all treatement

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with hereditary coagulopathies with arthropathy (i.e., chronic synovitis due to hemarthrosis), with X-ray and MRI (documenting synovitis) followed up at the Hemophilia Center HC-FMUSP.

排除标准

  • Patients who do not complete the planned assessments
  • Patients who do not accept to continue with the study.

结局指标

主要结局

Reduction of synovium thickness by embolization

时间窗: 6 months

Measure (in milimeters) changes of synovial thickness in patients with hereditary coagulopathies with arthropathy due to hemarthrosis with MRI (measure synovium thickness)

次要结局

  • Reduction of synovitis by embolization(1, 3 12, 24, 36, 48 and 60 months)
  • Balance and fall risk(1, 3, 6, 12, 24, 36, 48, 60 months)
  • Pain of the affected joint(1, 3, 6, 12, 24, 36, 48, 60 months)
  • Inferior limb strength(1, 3, 6, 12, 24, 36, 48, 60 months)
  • Quality of life of the patient(1, 3, 6, 12, 24, 36, 48, 60 months)
  • Functional capacity(1, 3, 6, 12, 24, 36, 48, 60 months)
  • Physical capacity(1, 3, 6, 12, 24, 36, 48, 60 months)
  • Stifness(1, 3, 6, 12, 24, 36, 48, 60 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验